| 95% CI | 95% confidence interval |
| AIC | Akaike’s information criterion |
| AM | arithmetic mean |
| BMC | benchmark concentration |
| BMCh | benchmark concentration-human |
| BMCL | benchmark concentration (95% CI Lower Bound) |
| BMCU | benchmark concentration (95% CI Upper Bound) |
| BMD | benchmark dose |
| BMDL | benchmark dose (95% CI lower bound) |
| BMDU | benchmark dose (95% CI upper bound) |
| CNTs | Carbon nanotubes |
| EFinter | interspecies extrapolation factor |
| EFintra | intraspecies extrapolation factor |
| ES | exposure scenario |
| EXP | exposure data distribution |
| GM | geometric mean |
| GNPs | graphene nanoplatelets |
| GSD | geometric standard deviation |
| HBGV | health-based guidance value |
| LOAEL | lowest-observed adverse effect level |
| MN | manufactured (engineered) nanomaterial |
| MWCNTs | multiwalled carbon nanotubes |
| MT | measurement technique |
| NOAEL | no-observed-adverse-effect level |
| NWH | non-working hours |
| OEL | occupational exposure level |
| RA | risk assessment |
| RCR | risk characterization ratios |
| REL | recommended exposure limit |
| SD | standard deviation |
| SWCNTs | single-walled carbon nanotubes |
| TWA | time-weighted average |
| UFi | uncertainty factor |
| WE | work events |
| WH | working hours |